Diagnostic and prognostic electrocardiographic features in patients with hypertrophic cardiomyopathy. (26th April 2023)

• Record Type: Journal Article
• Authors: Bernardini, Andrea; Crotti, Lia; Olivotto, Iacopo; Cecchi, Franco
• Is Part Of: European heart journal supplements. Volume 25(2023)Supplement C
• Page Start: C173
• Page End: C178
• Publication Date: 2023-04-26
• Subjects: Hypertrophic cardiomyopathy -- Electrocardiogram -- Diagnosis -- Prognosis; Cardiology -- Periodicals; Cardiology -- Europe -- Periodicals; 616.12005
• DOI: 10.1093/eurheartjsupp/suad074
• Languages: English
• ISSNs: 1520-765X

Abstract

Abstract: The standard 12-lead electrocardiogram (ECG) represents a cornerstone for the diagnosis and evaluation of hypertrophic cardiomyopathy (HCM), the most common genetically determined heart muscle disease, due to its cost-effectiveness and wide availability. The ECG may surprisingly look normal in 4–6% of adult patients, and in less than 3% of paediatric patients, but it is abnormal in the vast majority of the remaining patients. 'Specific' features comprise pathological Q-waves, deep S-waves in V1–V3, or high R-waves in V4–V6 due to left ventricular hypertrophy with T-wave (TW) depression or negative TWs. Negative giant TWs are often found in apical HCM. However, in many patients, the ECG may only show non-specific ST–T changes with diphasic or flat TWs. An isolated inverted TW in lateral leads (usually aVL) may be the only marker for HCM in some patients. Electrocardiogram helps to diagnose sarcomeric HCM and distinguish it from different phenocopies, such as cardiac amyloidosis, glycogen storage, or Fabry disease. Electrocardiogram may also have a prognostic role, identifying high-risk features that could impact the clinical outcome.